Skip to content
healthcare.dev

Oxybutynin Chloride Extended Release

NDC 43063-790, Oxybutynin Chloride, tablet, extended release, from PD-Rx Pharmaceuticals, Inc..

Product NDC
43063-790
Status
Listed
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078503
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43063-790 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE10 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
43063-790-904306307909090 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-790-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b5653b7e-1e3b-4da3-b3a2-33318f448c67

Use it

Look up 43063-790 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43063-790 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43063-790. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.